Stromal MED12 exon 2 mutations in complex fibroadenomas of the breast.
Edaise M Da SilvaFrancisco BecaAna Paula Martins SebastiaoMelissa P MurrayCatarina SilveiraArnaud Da Cruz PaulaFresia ParejaHannah Y WenTimothy M D' AlfonsoMarcia EdelweissBritta WeigeltEdi BrogiJorge S Reis-FilhoHong ZhangPublished in: Journal of clinical pathology (2020)
Like conventional fibroadenomas, MED12 exon 2 mutations appear to be restricted to the stromal component of CFAs, supporting the notion that CFAs are stromal neoplasms.
Keyphrases